TODAY Sydney medical scientist Brian Morris can celebrate the climax of his 40-year hunt to uncover a secret central to the cause of high blood pressure.

The Prescription drug market for the treatment of Hypertension is to continue to rise in value from the $25 billion market that it already accounts for today. These are the findings from the latest visiongain report investigating this market area, "The World Hypertension Market 2005-2010".

(PRWeb November 13, 2005)

Read the full story at

HCG Diet Direct cites research connecting hypertension and obesity. The solution for both is the same: healthy weight loss.

(PRWeb June 09, 2010)

Read the full story at

Blood pressure-lowering medications work much better if they are taken at bedtime rather than in the morning, according to a landmark study that could transform the way hypertension is treated.

Medtronic Inc. announced today the start of SYMPLICITY HTN-3, the company's U.S. clinical trial of the Symplicity Renal Denervation System for treatment-resistant hypertension.